BioSpace News Archive

Servier Canada announces Positive Results of the ENTRUST-AF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation

Servier Canada announces results from ENTRUST-AF PCI, the first large randomised study to evaluate the efficacy and safety of once-daily edoxaban plus a P2Y12 inhibitor against a regimen of vitamin K antagonist plus P2Y12 inhibitor and acetyl salicylic acid in atrial fibrillation patients following successful percutaneous coronary intervention.

September 3, 2019
·
9 min read
Pharm Country

Osteo Science Foundation Announces Global Initiatives

Improved patient care through advances in regenerative medicine has been the motivation of Osteo Science Foundation since its inception. The foundation was initially established to serve American and Canadian Oral and CranioMaxillofacial Surgeons

September 3, 2019
·
2 min read
Job Trends

“What is the ‘Surprise’ in Medical Bills?” Asks the Journal of American Physicians and Surgeons

Patients who receive a “surprise medical bill” are surprised because they thought they had insurance, and that the insurer was supposed to pay.

September 3, 2019
·
2 min read
Pharm Country

New Study: Low-Intensity Warfarin Not as Effective as Conventional Warfarin to Prevent Clots after Joint Replacement

In a new study, researchers at Hospital for Special Surgery (HSS), Washington University School of Medicine in St. Louis, and their colleagues report that a low-intensity regimen of warfarin does not appear to be as effective as conventional dosing of the blood thinner at preventing clots or death after joint-replacement surgery.

September 3, 2019
·
6 min read
Business

Medicx Hires Scott Magnano as Chief Financial Officer

Medicx Media Solutions (https://medicxmedia.com), the leading analytics-driven healthcare marketing solutions company, today announced that Scott Magnano joins the company as Chief Financial Officer.

September 3, 2019
·
2 min read
Business

APhA names Ilisa Bernstein senior vice president, pharmacy practice and government affairs

The American Pharmacists Association (APhA) has named Ilisa Bernstein, PharmD, JD, FAPhA, as its new Senior Vice President of Pharmacy Practice and Government Affairs, effective October 14

September 3, 2019
·
2 min read
BioMidwest

Hyundai Hope On Wheels Presents Siteman Kids At St. Louis Children’s Hospital With Hyundai Young Investigator And Scholar Hope Grant Totaling $500,000 To Support Pediatric Cancer Research

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

September 3, 2019
·
5 min read
Drug Development

Allegro Ophthalmics to Present the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the 19th EURETINA Congress and The Retina Society 2019 Annual Meeting

Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel therapies that regulate select integrin functions for the treatment of ocular diseases, today announced that the results of its U.S. Phase 2 study evaluating risuteganib (Luminate®) for the treatment of intermediate nonexudative age-related macular degeneration (dry AMD) will be presented during the 19th European Society of Retina Specialists (EURETINA) Congress

September 3, 2019
·
3 min read
Biotech Bay

Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer

Data support use of Afirma Xpression Atlas to inform surgery and treatment decisions at time of diagnosis

September 3, 2019
·
7 min read
Biotech Bay

Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract

Freie Universität Berlin uses company’s cutting-edge tools to examine effects of ecdysterone

September 3, 2019
·
2 min read